Compendia Bioscience

09.23.09 \|		Compendia Bioscience Announces the Release of Oncomine 4 Research Edition

04.28.09 \|		Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development

03.26.09 \|		Compendia Bioscience Releases Oncomine Concepts Edition 4.0

03.10.09 \|		On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability

06.10.08 \|		Oncomine™ Again Key To Prostate Cancer Discovery

06.05.08 \|		GlaxoSmithKline Signs Licensing Agreement with Compendia Bioscience

02.19.08 \|		On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments

11.04.07 \|		Compendia Bioscience Signs Oncomine™ Licensing Agreement with AstraZeneca

10.16.07 \|		Compendia Bioscience Announces the Release and Availability of Oncomine™ Research Premium Edition

10.11.07 \|		Compendia Bioscience Announces the Receipt of a $2.4M SBIR Award and Related Management Changes

08.02.07 \|		Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications

06.05.07 \|		Compendia Bioscience Announces Commercial Release and Availability of Oncomine™ Concepts Map

04.16.07 \|		Use of Oncomine™ Concepts Map to Study and Understand Molecular Profiling of Cancer to be Presented by Chief Science Officer of Compendia Bioscience

02.22.07 \|		Compendia Bioscience and Ingenuity Systems Partner to Integrate Cancer Gene Signature Data with Network Analysis Tools

02.13.07 \|		On First Anniversary, Compendia Bioscience Announces Completion of Management Team and Acquisition of First Ten Customers